195 related articles for article (PubMed ID: 34502051)
1. Laboratory Investigation of Hybrid IgG4 k/λ in MuSK Positive Myasthenia Gravis.
Basile U; Napodano C; Gulli F; Pocino K; Di Santo R; Todi L; Basile V; Provenzano C; Ciasca G; Marino M
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502051
[TBL] [Abstract][Full Text] [Related]
2. IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients.
Koneczny I; Stevens JA; De Rosa A; Huda S; Huijbers MG; Saxena A; Maestri M; Lazaridis K; Zisimopoulou P; Tzartos S; Verschuuren J; van der Maarel SM; van Damme P; De Baets MH; Molenaar PC; Vincent A; Ricciardi R; Martinez-Martinez P; Losen M
J Autoimmun; 2017 Feb; 77():104-115. PubMed ID: 27965060
[TBL] [Abstract][Full Text] [Related]
3. Functional monovalency amplifies the pathogenicity of anti-MuSK IgG4 in myasthenia gravis.
Vergoossen DLE; Plomp JJ; Gstöttner C; Fillié-Grijpma YE; Augustinus R; Verpalen R; Wuhrer M; Parren PWHI; Dominguez-Vega E; van der Maarel SM; Verschuuren JJ; Huijbers MG
Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33753489
[TBL] [Abstract][Full Text] [Related]
4. Long-Lasting Rituximab-Induced Reduction of Specific-But Not Total-IgG4 in MuSK-Positive Myasthenia Gravis.
Marino M; Basile U; Spagni G; Napodano C; Iorio R; Gulli F; Todi L; Provenzano C; Bartoccioni E; Evoli A
Front Immunol; 2020; 11():613. PubMed ID: 32431692
[TBL] [Abstract][Full Text] [Related]
5. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
[TBL] [Abstract][Full Text] [Related]
6. IgG4-mediated autoimmune diseases: a niche of antibody-mediated disorders.
Huijbers MG; Plomp JJ; van der Maarel SM; Verschuuren JJ
Ann N Y Acad Sci; 2018 Feb; 1413(1):92-103. PubMed ID: 29377160
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic IgG4 subclass autoantibodies in MuSK myasthenia gravis.
Plomp JJ; Huijbers MG; van der Maarel SM; Verschuuren JJ
Ann N Y Acad Sci; 2012 Dec; 1275():114-22. PubMed ID: 23278586
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms associated with the pathogenicity of antibodies against muscle-specific kinase in myasthenia gravis.
Mori S; Shigemoto K
Autoimmun Rev; 2013 Jul; 12(9):912-7. PubMed ID: 23537506
[TBL] [Abstract][Full Text] [Related]
9. A retrospective multicenter study on clinical and serological parameters in patients with MuSK myasthenia gravis with and without general immunosuppression.
Koneczny I; Mané-Damas M; Zong S; De Haas S; Huda S; van Kruining D; Damoiseaux J; De Rosa A; Maestri M; Guida M; Molenaar P; Van Damme P; Fichtenbaum A; Perkmann T; De Baets M; Lazaridis K; Zouvelou V; Tzartos S; Ricciardi R; Losen M; Martinez-Martinez P
Front Immunol; 2024; 15():1325171. PubMed ID: 38715598
[TBL] [Abstract][Full Text] [Related]
10. The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.
Koneczny I; Cossins J; Vincent A
J Anat; 2014 Jan; 224(1):29-35. PubMed ID: 23458718
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune Pathology in Myasthenia Gravis Disease Subtypes Is Governed by Divergent Mechanisms of Immunopathology.
Fichtner ML; Jiang R; Bourke A; Nowak RJ; O'Connor KC
Front Immunol; 2020; 11():776. PubMed ID: 32547535
[TBL] [Abstract][Full Text] [Related]
12. Passive transfer models of myasthenia gravis with muscle-specific kinase antibodies.
Verschuuren JJGM; Plomp JJ; Burden SJ; Zhang W; Fillié-Grijpma YE; Stienstra-van Es IE; Niks EH; Losen M; van der Maarel SM; Huijbers MG
Ann N Y Acad Sci; 2018 Feb; 1413(1):111-118. PubMed ID: 29356029
[TBL] [Abstract][Full Text] [Related]
13. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
Cole RN; Reddel SW; Gervásio OL; Phillips WD
Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
[TBL] [Abstract][Full Text] [Related]
14. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
[TBL] [Abstract][Full Text] [Related]
15. Is MuSK myasthenia gravis linked to IgG4-related disease?
Raibagkar P; Ferry JA; Stone JH
J Neuroimmunol; 2017 Apr; 305():82-83. PubMed ID: 28284351
[TBL] [Abstract][Full Text] [Related]
16. Relation of HLA-DRB1 to IgG4 autoantibody and cytokine production in muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG).
Çebi M; Durmuş H; Yılmaz V; Yentür SP; Aysal F; Oflazer P; Parman Y; Deymeer F; Saruhan-Direskeneli G
Clin Exp Immunol; 2019 Aug; 197(2):214-221. PubMed ID: 30929252
[TBL] [Abstract][Full Text] [Related]
17. MuSK antibodies, lessons learned from poly- and monoclonality.
Vergoossen DLE; Augustinus R; Huijbers MG
J Autoimmun; 2020 Aug; 112():102488. PubMed ID: 32505442
[TBL] [Abstract][Full Text] [Related]
18. MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4.
Huijbers MG; Zhang W; Klooster R; Niks EH; Friese MB; Straasheijm KR; Thijssen PE; Vrolijk H; Plomp JJ; Vogels P; Losen M; Van der Maarel SM; Burden SJ; Verschuuren JJ
Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20783-8. PubMed ID: 24297891
[TBL] [Abstract][Full Text] [Related]
19. MuSK myasthenia gravis monoclonal antibodies: Valency dictates pathogenicity.
Huijbers MG; Vergoossen DL; Fillié-Grijpma YE; van Es IE; Koning MT; Slot LM; Veelken H; Plomp JJ; van der Maarel SM; Verschuuren JJ
Neurol Neuroimmunol Neuroinflamm; 2019 May; 6(3):e547. PubMed ID: 30882021
[TBL] [Abstract][Full Text] [Related]
20. Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients.
Basile U; Marino M; Napodano C; Pocino K; Alboini PE; Gulli F; Evoli A; Provenzano C; Bartoccioni E
J Immunol Res; 2018; 2018():9646209. PubMed ID: 29765992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
